Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 3
2006 4
2007 4
2008 3
2009 1
2010 1
2011 3
2012 2
2013 2
2014 2
2015 4
2016 4
2017 4
2018 5
2019 2
2020 8
2021 11
2022 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
T Cell Responses against Orthopoxviruses in HIV-Positive Patients.
Stefanie S, Koldehoff M, Schenk-Westkamp P, Horn PA, Esser S, Lindemann M. Stefanie S, et al. Among authors: koldehoff m. Vaccines (Basel). 2024 Jan 27;12(2):131. doi: 10.3390/vaccines12020131. Vaccines (Basel). 2024. PMID: 38400115 Free PMC article.
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
Stemler J, Mellinghoff SC, Khodamoradi Y, Sprute R, Classen AY, Zapke SE, Hoenigl M, Krause R, Schmidt-Hieber M, Heinz WJ, Klein M, Koehler P, Liss B, Koldehoff M, Buhl C, Penack O, Maschmeyer G, Schalk E, Lass-Flörl C, Karthaus M, Ruhnke M, Cornely OA, Teschner D. Stemler J, et al. Among authors: koldehoff m. J Antimicrob Chemother. 2023 Aug 2;78(8):1813-1826. doi: 10.1093/jac/dkad143. J Antimicrob Chemother. 2023. PMID: 37311136 Free PMC article. Review.
AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants.
Giesen N, Busch E, Schalk E, Beutel G, Rüthrich MM, Hentrich M, Hertenstein B, Hirsch HH, Karthaus M, Khodamoradi Y, Koehler P, Krüger W, Koldehoff M, Krause R, Mellinghoff SC, Penack O, Sandherr M, Seggewiss-Bernhardt R, Spiekermann K, Sprute R, Stemler J, Weissinger F, Wörmann B, Wolf HH, Cornely OA, Rieger CT, von Lilienfeld-Toal M. Giesen N, et al. Among authors: koldehoff m. Eur J Cancer. 2023 Mar;181:102-118. doi: 10.1016/j.ejca.2022.11.030. Epub 2022 Dec 10. Eur J Cancer. 2023. PMID: 36652889 Free PMC article. Review.
Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment.
Thümmler L, Konik M, Lindemann M, Fisenkci N, Koldehoff M, Gäckler A, Horn PA, Theodoropoulos F, Taube C, Zettler M, Anastasiou OE, Braß P, Jansen S, Witzke O, Rohn H, Krawczyk A. Thümmler L, et al. Among authors: koldehoff m. Front Immunol. 2022 Oct 13;13:980698. doi: 10.3389/fimmu.2022.980698. eCollection 2022. Front Immunol. 2022. PMID: 36311723 Free PMC article.
Pregnancies and Neonatal Outcomes in Patients with Sickle Cell Disease (SCD): Still a (High-)Risk Constellation?
Proske P, Distelmaier L, Aramayo-Singelmann C, Koliastas N, Iannaccone A, Papathanasiou M, Temme C, Klump H, Lenz V, Koldehoff M, Carpinteiro A, Reinhardt HC, Köninger A, Röth A, Yamamoto R, Dührsen U, Alashkar F. Proske P, et al. Among authors: koldehoff m. J Pers Med. 2021 Aug 30;11(9):870. doi: 10.3390/jpm11090870. J Pers Med. 2021. PMID: 34575647 Free PMC article.
59 results